Jamie Simpson is an accomplished individual with extensive experience in medicinal chemistry. They have held various leadership positions at companies such as PureTech Health, Glyph Biosciences, AstraZeneca, and Vertex Pharmaceuticals. Their expertise lies in the development of lipid prodrug technology platforms, fragment-based drug discovery, and bioactive natural products. Jamie has also been actively involved in teaching and research positions at Monash University, where they have collaborated with PhD students and academic groups. With a Ph.D. in Organic Chemistry from The University of Queensland, Jamie has a strong background in chemistry, drug discovery, and enzyme inhibitor design.
January 1, 2024 - present
January, 2022
January, 2020
January, 2019
October, 2017